- Home
- CABO vs PHAT Comparison
CABO vs PHAT Comparison
Compare CABO & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABO
- PHAT
- Stock Information
- Founded
- CABO 1980
- PHAT 2018
- Country
- CABO United States
- PHAT United States
- Employees
- CABO N/A
- PHAT N/A
- Industry
- CABO Cable & Other Pay Television Services
- PHAT Biotechnology: Pharmaceutical Preparations
- Sector
- CABO Telecommunications
- PHAT Health Care
- Exchange
- CABO Nasdaq
- PHAT Nasdaq
- Market Cap
- CABO 717.5M
- PHAT 640.9M
- IPO Year
- CABO N/A
- PHAT 2019
- Fundamental
- Price
- CABO $132.95
- PHAT $9.74
- Analyst Decision
- CABO Hold
- PHAT Strong Buy
- Analyst Count
- CABO 3
- PHAT 5
- Target Price
- CABO $171.00
- PHAT $16.40
- AVG Volume (30 Days)
- CABO 244.4K
- PHAT 1.0M
- Earning Date
- CABO 07-31-2025
- PHAT 08-07-2025
- Dividend Yield
- CABO 6.66%
- PHAT N/A
- EPS Growth
- CABO N/A
- PHAT N/A
- EPS
- CABO N/A
- PHAT N/A
- Revenue
- CABO $1,542,441,000.00
- PHAT $114,039,000.00
- Revenue This Year
- CABO N/A
- PHAT $194.40
- Revenue Next Year
- CABO N/A
- PHAT $103.23
- P/E Ratio
- CABO N/A
- PHAT N/A
- Revenue Growth
- CABO N/A
- PHAT 1049.82
- 52 Week Low
- CABO $117.54
- PHAT $2.21
- 52 Week High
- CABO $437.00
- PHAT $19.71
- Technical
- Relative Strength Index (RSI)
- CABO 46.24
- PHAT 61.57
- Support Level
- CABO $127.34
- PHAT $8.03
- Resistance Level
- CABO $154.21
- PHAT $10.09
- Average True Range (ATR)
- CABO 8.19
- PHAT 0.66
- MACD
- CABO -0.17
- PHAT 0.06
- Stochastic Oscillator
- CABO 17.51
- PHAT 85.89
About CABO Cable One Inc.
Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.